B
Bernd W. Scheithauer
Researcher at Mayo Clinic
Publications - 729
Citations - 58507
Bernd W. Scheithauer is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Adenoma & Pituitary adenoma. The author has an hindex of 119, co-authored 729 publications receiving 55985 citations. Previous affiliations of Bernd W. Scheithauer include University of North Dakota & University of Michigan.
Papers
More filters
Journal ArticleDOI
Anaplasia in pilocytic astrocytoma predicts aggressive behavior.
TL;DR: PA with anaplastic features exhibits a spectrum of morphologies and is associated with decreased survival when compared with typical PA, and paralleled that of St Anne-Mayo grades 2 and 3 diffuse astrocytomas, respectively.
Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients.
TL;DR: The largest success rate (88%) was among female patients with microadenoma and preoperative serum prolactin values of less than 100 ng/ml, and the largest failure rate (60%) was among male patients withmicroadenoma.
Journal ArticleDOI
Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region.
TL;DR: The purpose of this study was to assess the frequency of plexiform schwannoma by location, to determine their syndromic association, and to analyze the clinicopathologic features of tumors affecting the head and neck region.
Journal ArticleDOI
Supratentorial gliomas: a comparative study by grade and histologic type.
TL;DR: These survival data suggest that both low-grade and high-grade supratentorial gliomas have outcomes which are highly dependent upon histologic type.
Journal ArticleDOI
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.
Christine E. Fuller,Robert E. Schmidt,Kevin A. Roth,Peter C. Burger,Bernd W. Scheithauer,Ruma Banerjee,Kathryn Trinkaus,Richard A. Lytle,Arie Perry +8 more
TL;DR: Two distinct genetic subsets are identifiable by FISH in morphologically ambiguous gliomas, and both histological grading and molecular analysis yield prognostically useful information.